captured official filings
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY
Cordyceps Sunshine Biotech Holdings Co., Ltd.
Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.
captured official filings
captured official filings
captured official filings
WHAT THIS AUTOMATES
One evidence index instead of a manual filing hunt.
It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.
PROFESSIONAL DELIVERY LAYER
What teams can pay to automate next.
Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.
MACHINE-DETECTED FILING CHANGE RADAR
Public registration text delta
Comparing F-1/A filed 2023-03-06 with F-1/A filed 2023-03-20.
Tracked-term count changes
Counts are navigation signals, not conclusions. Open both official filings to determine materiality.
- offering39 → 50+11
- control27 → 18-9
- management25 → 19-6
- shares82 → 81-1
Candidate disclosure excerpts
Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.
New in latest filing
- After the effective date of the registration statement relating to this prospectus, we hope to have a market -maker file an application with the Financial Industry Regulatory Authority (“FINRA”) for our ordinary shares to be eligible for quotation on OTCQB .
- On February 17, 2023, the CSRC released the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies, or the Trial Measures, and five supporting guidelines, which will come into effect on March 31, 2023.
- Such risks could result in a material change in our operations and/or the value of our ordinary shares or could significantly limit or completely hinder our ability to offer or continue to offer our ordinary shares and/or other securities to investors and cause the value of such securities to significantly decline or be worthles
Present in earlier filing, not found in latest
- The Selling Shareholders may offer all or part of the shares for resale from time to time through public or private transactions, at a fixed price of $0.02 per share until the ordinary shares are listed on a national securities exchange or quoted on the OTC Markets Group, Inc. (“OTC Markets”) , at which time they m
- After the effective date of the registration statement relating to this prospectus, we hope to have a market -maker file an application with the Financial Industry Regulatory Authority (“FINRA”) for our ordinary shares to be eligible for quotation on the over -the -counter markets administered by the OTC Markets .
- Such risks could result in a material   Table of Contents change in our operations and/or the value of our ordinary shares or could significantly limit or completely hinder our ability to offer or continue to offer our ordinary shares and/or other securities to investors and cause the value of such securities to significa
Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.
DOWNLOAD EDITION
Save a project-ready issuer record.
US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.
- Source-linked filing chronology and registration path
- Machine-detected amendment and tracked-term change view
- Official-source index for project-file archiving and downloadable CSV export
Secure checkout by PayPal.
AUTOMATED EVIDENCE SNAPSHOT
Unlock download · US$29Save this source-linked record
Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.
OFFICIAL SEC SUBMISSIONS
Open Evidence Snapshot →Captured filing chronology
- 6-KReporting & material eventsOpen SEC filing →
- 6-KReporting & material eventsOpen SEC filing →
- 20-FReporting & material eventsOpen SEC filing →
- 6-KReporting & material eventsOpen SEC filing →
- 20-F/AReporting & material eventsOpen SEC filing →
- 20-FReporting & material eventsOpen SEC filing →
- 6-KReporting & material eventsOpen SEC filing →
- 20-F/AReporting & material eventsOpen SEC filing →
- 20-FReporting & material eventsOpen SEC filing →
- 6-KReporting & material eventsOpen SEC filing →
- 6-KReporting & material eventsOpen SEC filing →
- 6-KReporting & material eventsOpen SEC filing →
- 20-FReporting & material eventsOpen SEC filing →
- 424B4Registration & offeringOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1/ARegistration & offeringOpen SEC filing →
- F-1Registration & offeringOpen SEC filing →
Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.